en · de · es · fr · pt
cardarine-notes.peptides6579.com › Guide › Detection, Stability, And Quality — Reference Sheet

Detection, Stability, And Quality — Reference Sheet

By Editorial Desk · published 2026-01-31 · last reviewed 2026-02-28 · Guide

If you have been reading about LC-MS/MS and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.

Last reviewed on 2026-02-28. Where a claim depends on a specific study, the study is described rather than over-claimed.

Detection, Stability, and Quality

Stability of GW501516 depends on form, temperature, light exposure, and moisture. Solid reference material is typically stored frozen or refrigerated in a desiccator and protected from light. Solutions in organic solvents such as dimethyl sulfoxide are often kept frozen in aliquots to reduce freeze-thaw cycling. Aqueous solubility is low, so aqueous stock solutions can be difficult to prepare without cosolvents. Degradation may appear as changes in chromatographic purity or mass spectral signal. Stability studies are needed to establish shelf life for any specific preparation.

Quality assessment for cardarine samples usually combines identity, purity, and impurity testing. Nuclear magnetic resonance spectroscopy and mass spectrometry can confirm molecular structure, while high-performance liquid chromatography estimates purity. Certificates of analysis from testing laboratories may list these results, but they do not establish safety or legality. In the absence of approved manufacturing, products sold online may contain the wrong compound, variable amounts, or unlisted contaminants. Independent verification is therefore central to analytical work and to interpreting any reported biological activity.

Identity and Pharmacological Mechanism

Cardarine is a common name for GW501516, a synthetic compound studied for its effects on lipid and glucose metabolism. It functions as an agonist at peroxisome proliferator-activated receptor delta, or PPARδ, a nuclear receptor that influences gene expression. The molecule is not a steroid, nor is it a selective androgen receptor modulator. It is also known in research and sports literature as GW-501516 and endurobol. Early laboratory work examined its metabolic activity in cell cultures and animal models.

Activation of PPARδ changes transcription of genes involved in fatty acid transport, mitochondrial function, and skeletal muscle fuel preference. In rodent studies, pharmacological PPARδ activation was associated with increased endurance and altered body composition. These findings generated interest in performance enhancement, but species differences and study designs limit direct extrapolation to humans. Small human trials were conducted in the 2000s and later discontinued. The extent to which cardarine produces similar metabolic or performance effects in people remains an open question.

The compound is typically described as a laboratory compound rather than a therapeutic product. Published reports have explored its role in lipid disorders, insulin sensitivity, and exercise metabolism, yet no major drug regulator has approved it for medical use. Commercial samples sold under the cardarine name may vary in purity and identity. Analytical confirmation is therefore necessary when the material is discussed in scientific or regulatory contexts. Its classification as a prohibited substance in sport further shapes how it is studied and reported.

Cardarine at a glance

PropertyValueNotes
AppearanceWhite to off-white powderCommon for reference-grade material.
SolubilityLow in waterDissolves in DMSO and some organic solvents.
Typical storage-20 °C, desiccatedProtect from light and moisture.
Analytical methodLC-MS/MSUsed for trace detection in biological matrices.
Purity assessmentHPLC with UV detectionOften combined with NMR and mass spectrometry.

Preclinical Findings and Safety Signals

Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.

Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.

Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.

Related pages on this site

Detection and Regulatory Landscape

Cardarine is explicitly prohibited by the World Anti-Doping Agency under the class of PPARδ agonists. Its presence in urine or blood samples can be detected using mass spectrometry-based methods, often liquid chromatography-tandem mass spectrometry. Athletes who test positive may face sanctions, including bans from competition. The compound is also regulated as a prescription-only or unapproved drug in many countries. Enforcement varies by jurisdiction, and some regions treat it as a controlled substance. Online sales may occur despite these restrictions, creating quality and legal risks.

Laboratory detection of cardarine typically involves sample preparation followed by chromatographic separation and mass spectrometric identification. Urine is the most common matrix for anti-doping tests, though blood and hair have also been explored. Methods can target the parent compound or its metabolites, depending on the expected window of detection. Reference standards are required for accurate quantification. Matrix effects and dilution can influence results, so laboratories use internal standards and validation protocols. The exact detection window varies with dose, route, and individual metabolism.

A common misconception is that cardarine has been proven safe for human use. In reality, human clinical data are limited, and long-term animal studies have raised concerns about cancer. Another misconception is that it is a supplement or vitamin-like compound. It is a synthetic research chemical with no approved medical indication. Scientific discussion often focuses on its mechanism and detection rather than therapeutic use. Regulatory and anti-doping literature treats it primarily as a prohibited substance.

Notes from published material

2 November – Andy Street, the Mayor of the West Midlands, has written to the Home Secretary requesting that his office be granted the powers of the area's Police and Crime Commissioner after the next mayoral election because "crime in this region has more than doubled... and I simply cannot allow it to go on any longer". 5 November – The Metropolitan Police ends its relationship with adviser Attiq Malik after video emerged of him chanting a pro-Palestinian slogan during a speech to a group in 2021. Surrey County Council declares an emergency after thousands of properties are left without water following a technical problem at a Thames Water treatment works, which is attributed to Storm Ciarán. 7 November – Anastrozole, a drug used for a number of years to treat breast cancer, is licensed for use in England as a preventative option. West Yorkshire Police launch a murder investigation after a 15-year-old boy dies following a stabbing near a school in Leeds. He is later named as Alfie Lewis, a former student at Horsforth School. 9 November – A 14-year-old boy is remanded in custody charged with the murder of Alfie Lewis. Labour's Caroline Woodley is elected mayor of Hackney in London in a by-election. 10 November – Following trial and conviction at Leicester Crown Court, Katie Tidmarsh is sentenced to life imprisonment with a minimum term of 17 years for the 2012 murder of Ruby Thompson, a one-year-old child she had hoped to adopt.

These immobilized CSP are much more rugged and the "non-standard" solvents can be employed. Thus expanding the choice of co-solvent. The major strength of immobilized CSPs are high solvent versatility in selection of mobile phase composition, enhanced sample solubility, high selectivity, robustness and extended durability, excellent column efficiency, and broad application domain in the resolution of enantiomers. Solvent is a key factor in HPLC MD. More solvents to play with means better sample solubility, Improves resolution, and enables effective chiral method development.

It has been particularly successful at analyzing "decoy" structures from ab initio structure prediction. These decoys are notorious for getting local fragment motif structure correct, and forming some kernels of correct 3D tertiary structure but getting the full length tertiary structure wrong. In this twilight remote homology regime, Mammoth's e-values for the CASP protein structure prediction evaluation have been shown to be significantly more correlated with human ranking than SSAP or DALI. Mammoths ability to extract the multi-criteria partial overlaps with proteins of known structure and rank these with proper E-values, combined with its speed facilitates scanning vast numbers of decoy models against the PDB data base for identifying the most likely correct decoys based on their remote homology to known proteins.

Sources: en.wikipedia.org

Background from the literature

=== Protein-RNA interaction network identification === Protein-RNA interactions networks are identified using RNP-MaP correlations since multiple crosslink sites can be detected for a single RNA molecule. RNP-MaP correlations provide a complementary measure of protein binding to RNA independent of RNP-MaP sites. They are identified using a G-test framework known as RingMapper. RNP-MaP correlations require a single RNA molecule to form at least two crosslinks and arise from any of three scenarios:

== Education and early life == Robert Joseph Paton Williams was born on 25 February 1926 in Wallasey to Ernest Ivor Williams, a customs and excise officer at Liverpool, and Alice Williams (née Roberts), a milliner; he was the second of four children. Williams failed to gain a scholarship to Wallasey Grammar School, having missed six months’ schooling with diphtheria, but his parents paid for him to attend. He went on to gain a place and be awarded a Postmastership to read chemistry at Merton College, Oxford in 1944. For his final undergraduate research year he worked with analytical chemist Harry Irving. This enabled him to establish an order of the relative stabilities of metal–organic complexes along the latter half of the transition series manganese through zinc. From these findings he saw a parallel with the selective uptake of metal ions by organisms. Williams’s plan was to continue working with Irving for his DPhil, but he first visited the lab of Arne Tiselius at Uppsala University. He was impressed by what he saw there, and returned to Sweden after he gained his DPhil in 1950. During the longer stay he worked on protein purification and devised a method called gradient elution analysis.

== Diabetes == A study at the University of California, San Diego School of Medicine has shown that LTB4 promotes insulin resistance in obese mice. Obesity is the major cause of insulin resistance in type 2 diabetes.

The Selous Scouts was a special forces unit of the Rhodesian Army that operated during the Rhodesian Bush War from 1973 until the reconstitution of the country as Zimbabwe in 1980. It was mainly responsible for infiltrating the black majority population of Rhodesia and collecting intelligence on insurgents so that they could be attacked by regular elements of the security forces. The unit did this by forming small teams that posed as insurgents and usually included captured insurgents. Over time, the Selous Scouts increasingly attacked insurgents themselves and operated in the countries that neighboured Rhodesia. The unit developed a reputation for brutality and was responsible for attacking and killing civilians. The Selous Scouts were also involved in the Rhodesian chemical and biological weapons programme and used poisons and biological agents in some of its operations. The methods used by the unit led to the deaths of large numbers of insurgents, but proved counter-productive as they further alienated the black majority population from the white minority Rhodesian government and increased international opposition to the regime. Following the disbandment of the Selous Scouts after Rhodesia's transition to Zimbabwe, many of its members were recruited into the Apartheid-era South African security forces. They contributed to the adoption of the Selous Scouts' methods by the South African Defence Force and South African Police, and some took part in operations to undermine the government of Zimbabwe.

Sources: en.wikipedia.org

Further detail

It is a legal requirement that an assessment of major organ toxicity be performed (effects on the heart and lungs, brain, kidney, liver and digestive system), as well as effects on other parts of the body that might be affected by the drug (e.g., the skin if the new drug is to be delivered on or through the skin). Such preliminary tests are made using in vitro methods (e.g., with isolated cells), but many tests can only use experimental animals to demonstrate the complex interplay of metabolism and drug exposure on toxicity. However, aside from regulatory requirements, there is a broad range of other factors, such as patient requirements, that are considered during development and testing. The information gathered from this preclinical testing, as well as information on CMC, and submitted to regulatory authorities (in the US, to the FDA), as an Investigational New Drug (IND) application. If the IND is approved, development moves to the clinical phase.

The offerings of Patient CROs (Clinical CROs) comprise more than 30 tasks addressing the clinical part of pharmaceutical development at the interface between drugs, physicians, hospitals, and patients, such as the clinical development and selection of lead new drug compounds. As clinical trials represent the largest expense in pharmaceutical research, the market for Patient CROs is larger than for their product counterparts. Thus, the sales of the top tier firms, such as Charles River Laboratories, Fortrea, Parexel, PPD, Quintiles Transnational, all USA, and TCG Lifescience, India, are in the $1–$2 billion range, whereas the largest Product CROs have revenues of a few 100 million dollars.

An equianalgesic chart is a conversion chart that lists equivalent doses of analgesics (drugs used to relieve pain). Equianalgesic charts are used for calculation of an equivalent dose (a dose which would offer an equal amount of analgesia) between different analgesics. Tables of this general type are also available for NSAIDs, benzodiazepines, depressants, stimulants, anticholinergics and others. When using oral morphine as a baseline, the comparison of strengths of opioid analgesics is referred to as oral morphine equivalent.

Sources: en.wikipedia.org

Frequently asked questions

How is cardarine measured in biological samples?

LC-MS/MS is common, often after sample cleanup. The assay targets GW501516 or its metabolites.

What storage conditions are typical for reference material?

Reference material is usually kept cold, dry, and protected from light. Frozen aliquots reduce repeated freeze-thaw cycles.

Why can purity vary between products?

No approved pharmaceutical product exists, so manufacturing and quality controls are not standardized. Products may contain different compounds or impurities.

What is cardarine?

Cardarine is a common name for GW501516, a synthetic PPARδ agonist. It is not a steroid or a selective androgen receptor modulator. It was developed and studied as a research compound for metabolic pathways.

Network